We seek to quickly capture market share with this novel formulation of sildenafil citrate. We intend to aggressively market Sildenafil Oral Spray and build awareness among key opinion leaders and healthcare professionals, enabling us to build brand loyalty and to continually expand our market share. As the market matures, we intend to maintain our market position by leveraging our brand equity and name recognition in the market. We aim to win market dominance through product innovation and product line extensions. Our branding will enable us to develop trust and a deep emotional connection with patients.
Suggested unit (30mL bottle) Wholesale Acquisition Cost (WAC) of $60 is based on the following:
Aspargo is seeking to obtain FDA authorization to market the product in the United States pursuant to section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act. This regulation provides that new routes of administration for an approved drug qualify for an expedited form of approval.